Literature DB >> 19787721

Comprehensive adenosine stress perfusion MRI defines the etiology of chest pain in the emergency room: Comparison with nuclear stress test.

Jens Vogel-Claussen1, Jan Skrok, David Dombroski, Steven M Shea, Edward P Shapiro, Mark Bohlman, Christine H Lorenz, Joao A C Lima, David A Bluemke.   

Abstract

PURPOSE: To compare standard of care nuclear SPECT imaging with cardiac magnetic resonance imaging (MRI) for emergency room (ER) patients with chest pain and intermediate probability for coronary artery disease.
MATERIALS AND METHODS: Thirty-one patients with chest pain, negative electrocardiogram (ECG), and negative cardiac enzymes who underwent cardiac single photon emission tomography (SPECT) within 24 h of ER admission were enrolled. Patients underwent a comprehensive cardiac MRI exam including gated cine imaging, adenosine stress and rest perfusion imaging and delayed enhancement imaging. Patients were followed for 14 +/- 4.7 months.
RESULTS: Of 27 patients, 8 (30%) showed subendocardial hypoperfusion on MRI that was not detected on SPECT. These patients had a higher rate of diabetes (P = 0.01) and hypertension (P = 0.01) and a lower global myocardial perfusion reserve (P = 0.01) compared with patients with a normal cardiac MRI (n = 10). Patients with subendocardial hypoperfusion had more risk factors for cardiovascular disease (mean 4.4) compared with patients with a normal MRI (mean 2.5; P = 0.005). During the follow-up period, patients with subendocardial hypoperfusion on stress MRI were more likely to return to the ER with chest pain compared with patients who had a normal cardiac MRI (P = 0.02). Four patients did not finish the MR exam due to claustrophobia.
CONCLUSION: In patients with chest pain, diabetes and hypertension, cardiac stress perfusion MRI identified diffuse subendocardial hypoperfusion defects in the ER setting not seen on cardiac SPECT, which is suspected to reflect microvascular disease. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787721      PMCID: PMC3037112          DOI: 10.1002/jmri.21899

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  32 in total

1.  Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging.

Authors:  Igor Klem; John F Heitner; Dipan J Shah; Michael H Sketch; Victor Behar; Jonathan Weinsaft; Peter Cawley; Michele Parker; Michael Elliott; Robert M Judd; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2006-03-27       Impact factor: 24.094

2.  On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies.

Authors:  E V R Di Bella; D L Parker; A J Sinusas
Journal:  Magn Reson Med       Date:  2005-11       Impact factor: 4.668

3.  Feasibility of integrating high-spatial-resolution 3D breath-hold coronary MR angiography with myocardial perfusion and viability examinations.

Authors:  Thomas K F Foo; Vincent B Ho; Manojkumar Saranathan; Liu-quan Cheng; Hajime Sakuma; Dara L Kraitchman; Katherine C Wu; David A Bluemke
Journal:  Radiology       Date:  2005-06       Impact factor: 11.105

4.  Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy.

Authors:  Hajime Sakuma; Naohisa Suzawa; Yasutaka Ichikawa; Katsutoshi Makino; Tadanori Hirano; Kakuya Kitagawa; Kan Takeda
Journal:  AJR Am J Roentgenol       Date:  2005-07       Impact factor: 3.959

5.  Mechanisms of angina pectoris in syndrome X.

Authors:  A Maseri; F Crea; J C Kaski; T Crake
Journal:  J Am Coll Cardiol       Date:  1991-02       Impact factor: 24.094

Review 6.  Nuclear cardiology in acute coronary syndromes.

Authors:  H Bülow; M Schwaiger
Journal:  Q J Nucl Med Mol Imaging       Date:  2005-03       Impact factor: 2.346

7.  Prognostic value of quantitative stress myocardial perfusion imaging in unstable angina patients with negative cardiac enzymes and no new ischemic ECG changes.

Authors:  Habib A Dakik; Wayne S Hwang; Aman Jafar; Kay Kimball; Mario S Verani; John J Mahmarian
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

8.  Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Lu Wang; Michael Jerosch-Herold; David R Jacobs; Eyal Shahar; Aaron R Folsom
Journal:  J Am Coll Cardiol       Date:  2006-01-18       Impact factor: 24.094

9.  Assessment of coronary arteries with total study time of less than 30 minutes by using whole-heart coronary MR angiography.

Authors:  Hajime Sakuma; Yasutaka Ichikawa; Naohisa Suzawa; Tadanori Hirano; Katsutoshi Makino; Nozomu Koyama; Marc Van Cauteren; Kan Takeda
Journal:  Radiology       Date:  2005-08-26       Impact factor: 11.105

10.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography.

Authors:  E Nagel; H B Lehmkuhl; W Bocksch; C Klein; U Vogel; E Frantz; A Ellmer; S Dreysse; E Fleck
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

View more
  10 in total

Review 1.  Pharmacological stress cardiovascular magnetic resonance.

Authors:  Runyawan Chotenimitkhun; W Gregory Hundley
Journal:  Postgrad Med       Date:  2011-05       Impact factor: 3.840

Review 2.  Identification of left ventricular myocardial ischemia and cardiac prognosis with cardiovascular magnetic resonance: updates from 2008 to 2010.

Authors:  Runyawan Chotenimitkhun; W Gregory Hundley
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

3.  A Magnetic Resonance Imaging-Conditional External Cardiac Defibrillator for Resuscitation Within the Magnetic Resonance Imaging Scanner Bore.

Authors:  Ehud J Schmidt; Ronald D Watkins; Menekhem M Zviman; Michael A Guttman; Wei Wang; Henry A Halperin
Journal:  Circ Cardiovasc Imaging       Date:  2016-10       Impact factor: 7.792

4.  Stress cardiac MR imaging compared with stress echocardiography in the early evaluation of patients who present to the emergency department with intermediate-risk chest pain.

Authors:  John F Heitner; Igor Klem; Derek Rasheed; Abhinav Chandra; Han W Kim; Lowie M R Van Assche; Michele Parker; Robert M Judd; James G Jollis; Raymond J Kim
Journal:  Radiology       Date:  2013-12-10       Impact factor: 11.105

5.  Prognostic value of stress cardiac magnetic resonance imaging in patients with known or suspected coronary artery disease: a systematic review and meta-analysis.

Authors:  Michael J Lipinski; Courtney M McVey; Jeffrey S Berger; Christopher M Kramer; Michael Salerno
Journal:  J Am Coll Cardiol       Date:  2013-05-30       Impact factor: 24.094

6.  Cardiovascular magnetic resonance in systemic hypertension.

Authors:  Alicia M Maceira; Raad H Mohiaddin
Journal:  J Cardiovasc Magn Reson       Date:  2012-06-11       Impact factor: 5.364

Review 7.  Cardiac magnetic resonance and computed tomography angiography for clinical imaging of stable coronary artery disease. Diagnostic classification and risk stratification.

Authors:  Grigorios Korosoglou; Sorin Giusca; Gitsios Gitsioudis; Christian Erbel; Hugo A Katus
Journal:  Front Physiol       Date:  2014-08-06       Impact factor: 4.566

Review 8.  Multimodality Imaging in Ischemic Cardiomyopathy.

Authors:  John O Prior; Hoshang Farhad; Olivier Muller
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014

Review 9.  The emerging role of Cardiovascular Magnetic Resonance in the evaluation of hypertensive heart disease.

Authors:  Sophie Mavrogeni; Vasiliki Katsi; Vasiliki Vartela; Michel Noutsias; George Markousis-Mavrogenis; Genovefa Kolovou; Athanasios Manolis
Journal:  BMC Cardiovasc Disord       Date:  2017-05-23       Impact factor: 2.298

10.  Safety profile of adenosine stress cardiac MRI in a tertiary hospital in India.

Authors:  Vimal Raj; A Pudhiavan; V J Hrishikesh; Asik Ali; Richa Kothari
Journal:  Indian J Radiol Imaging       Date:  2021-01-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.